ASH announces seventh-round bridge grant recipients
MPN News | July 21st
MPN Research Foundation congratulates our MPN Challenge grantees Zhijian Qian, a PhD from the University of Illinois at Chicago and Ann Mullally,a MD at The Brigham and Women's Hospital for receiving the 2016 ASH Bridge Grant.
MPN News | March 1, 2014
Anti-fibrotic drug PRM-151 recruiting MF patients across the country
MPN News | July 4, 2016
The PROMOTE site has information on their clinical trial including which sites are actively recruiting people who have myelofibrosis.
Stanford and 23andMe partner on MPN
MPN News | July 5, 2016
Reported in Blood, 726 people with Polycythemia vera, essential thrombocythemia and myelofibrosis were compared to a control group.
Vice President Joe Biden addresses the 2016 ASCO audience
MPN News | June 7, 2016
The Cancer Moonshot is a new push for more teamwork in cancer research and application of innovation.
MPN updates from ASCO 2016
MPN News | June 8, 2016
Updates on clinical trials and research news for PV, ET and MF.
Gilead sponsors observational study on MPNs
MPN News | August 2, 2016
A research project sponsored by Gilead is currently seeking participants for a study about experience with MPN symptoms.
FDA OK's Pacritinib for some patients; Full clinical hold remains
MPN News | March 14, 2016
Pacritinib remains on full clinical hold, but per FDA patients receiving benefit are allowed to receive the drug under a Single Patient IND (SPI)/Compassionate use program.
New research out of UIC suggests racial disparities among those with MPN
MPN News | March 11, 2016
Researchers from the University of Illinois at Chicago have just published a study that demonstrated a difference between Caucasians and non-Caucasians for those with myeloproliferative neoplasms.
Medicare Approves Coverage for SCT
MPN News | February 19, 2016
Medicare has (somewhat) come through for people with Myelofibrosis by agreeing to provide coverage for those who qualify and are in need of a Stem Cell Transplant.
Update: Pacritinib Now on Full Clinical Hold
MPN News | February 10, 2016
The FDA has put the Phase 3 trials of Pacritinib on full clinical hold, noting overall survival results.
Zebrafish Shines Light on Melanoma and Provides Hope for MPN
MPN News | February 11, 2016
Dr. Leonard Zon of Boston Children's Hospital has made a discovery that shed light on the origins of cancer.
Blood Journal Reports that CALR Mutation Reduced with Pegasys
MPN News | December 11, 2015
In the journal Blood, Jean-Jacques Kiladjian and colleagues reported their findings that Pegylated interferon alpha induces hematological and molecular remission in CALR mutated essential thrombocythemia patients.
Cure Magazine honors MPNRF with MPN Hero honor
MPN News | December 10, 2015
Each year for the past three years, Cure Magazine and Incyte Corporation have recognized efforts within the MPN community with their MPN Hero award.